Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://aliviaudzn148596.prublogger.com/37927708/trelaglutide-exploring-a-new-option-for-chronic-diseases